Expression of TIPE family members in human colorectal cancer

Zhong,Mengya; Chen,Zhijian; Yan,Yang; Bahet,Argen; Cai,Xin; Chen,Huiyu; Ran,Honggang; Qu,Kaiyong; Han,Zhaopu; Zhuang,Guohong; Zhang,Shifeng; Wang,Yinan

doi:10.3892/ol.2020.12379

Expression of TIPE family members in human colorectal cancer

Authors:
- Mengya Zhong
- Zhijian Chen
- Yang Yan
- Argen Bahet
- Xin Cai
- Huiyu Chen
- Honggang Ran
- Kaiyong Qu
- Zhaopu Han
- Guohong Zhuang
- Shifeng Zhang
- Yinan Wang
View Affiliations

Affiliations: Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361005, P.R. China, Department of Gastrointestinal Surgery, Zhongshan Hospital of Xiamen University, Xiamen, Fujian 361004, P.R. China, Department of Basic Medical Science, School of Medicine, Xiamen University, Xiamen, Fujian 361005, P.R. China
Published online on: December 15, 2020 https://doi.org/10.3892/ol.2020.12379
Article Number: 118
Copyright: © Zhong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The tumor necrosis factor α‑induced protein 8 (TNFAIP8)‑like (TIPE) protein family comprises four members, namely TNFAIP8, TIPE1, TIPE2 and TIPE3, which are involved in multiple processes in cancer. The current study aimed to investigate the expression patterns and potential clinical roles of the TIPE family members in human colorectal cancer (CRC). Paired tumor and adjacent tissue samples were collected from 49 patients with CRC, and the relative mRNA expression levels of the TIPE family members in these samples were evaluated by using reverse transcription‑quantitative PCR, and the protein levels in five randomly selected pairs of tumor and adjacent tissue samples were detected by western blot analysis. The mRNA expression levels of the TIPE family members were significantly downregulated in CRC tumor tissues compared with those in the adjacent tissues; however, within each sample, TNFAIP8 and TIPE3 protein levels were only partially consistent with their mRNA levels. In addition, the mRNA expression levels between each pair of TIPE family members exhibited a positive linear relationship, and TIPE2 mRNA levels exhibited strong linear associations with those of TNFAIP8 and TIPE1. TNFAIP8 mRNA expression levels in tumor tissues were significantly associated with the tumor differentiation grade, and TIPE2 mRNA expression levels in tumor tissues were significantly associated with sex. TIPE1 and TIPE3 mRNA expression levels in tumor tissues exhibited no associations with patient clinicopathological characteristics. In addition, the mRNA expression patterns of the TIPE family members were analyzed using data from The Cancer Genome Atlas data set, and the results also demonstrated that TNFAIP8, TIPE2 and TIPE3 mRNA levels were downregulated in patients with colon adenocarcinoma compared with those in normal controls. These results provided evidence that the four members of the TIPE family may affect each other to mediate the carcinogenesis of CRC, and that TIPE2 may serve an important role in CRC.

View Figures

View References

1	Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA and Jemal A: Colorectal cancer statistics, 2020. CA Cancer J Clin. 70:145–164. 2020. View Article : Google Scholar : PubMed/NCBI
2	Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T: Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
3	Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP and Kuipers EJ: Colorectal cancer screening: A global overview of existing programmes. Gut. 64:1637–1649. 2015. View Article : Google Scholar : PubMed/NCBI
4	Lowe JM, Nguyen TA, Grimm SA, Gabor KA, Peddada SD, Li L, Anderson CW, Resnick MA, Menendez D and Fessler MB: The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. Cell Death Differ. 24:181–191. 2017. View Article : Google Scholar : PubMed/NCBI
5	Padmavathi G, Banik K, Monisha J, Bordoloi D, Shabnam B, Arfuso F, Sethi G, Fan L and Kunnumakkara AB: Novel tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE) family: Functions and downstream targets involved in cancer progression. Cancer Lett. 432:260–271. 2018. View Article : Google Scholar : PubMed/NCBI
6	Bordoloi D, Banik K, Shabnam B, Padmavathi G, Monisha J, Arfuso F, Dharmarajan A, Mao X, Lim LHK, Wang L, et al: TIPE family of proteins and its implications in different chronic diseases. Int J Mol Sci. 19:29742018. View Article : Google Scholar
7	Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, et al: TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 133:415–426. 2008. View Article : Google Scholar : PubMed/NCBI
8	Zhang S, Zhang Y, Wei X, Zhen J, Wang Z, Li M, Miao W, Ding H, Du P, Zhang W, et al: Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim Biophys Acta. 1802:1078–1086. 2010. View Article : Google Scholar : PubMed/NCBI
9	You Z, Ouyang H, Lopatin D, Polver PJ and Wang CY: Nuclear factor-kappa B-inducible death effector domain-containing protein suppresses tumor necrosis factor-mediated apoptosis by inhibiting caspase-8 activity. J Biol Chem. 276:26398–26404. 2001. View Article : Google Scholar : PubMed/NCBI
10	Kumar D, Whiteside TL and Kasid U: Identification of a novel tumor necrosis factor-alpha-inducible gene, SCC-S2, containing the consensus sequence of a death effector domain of fas-associated death domain-like interleukin-1beta-converting enzyme-inhibitory protein. J Biol Chem. 275:2973–2978. 2000. View Article : Google Scholar : PubMed/NCBI
11	Zhang L, Liu R, Luan YY and Yao YM: Tumor necrosis factor-α induced protein 8: Pathophysiology, clinical significance, and regulatory mechanism. Int J Biol Sci. 14:398–405. 2018. View Article : Google Scholar : PubMed/NCBI
12	Niture S, Dong X, Arthur E, Chimeh U, Niture SS, Zheng W and Kumar D: Oncogenic role of tumor necrosis factor α-induced protein 8 (TNFAIP8). Cells. 8:92018. View Article : Google Scholar
13	Laliberte B, Wilson AM, Nafisi H, Mao H, Zhou YY, Daigle M and Albert PR: TNFAIP8: A new effector for Galpha(i) coupling to reduce cell death and induce cell transformation. J Cell Physiol. 225:865–874. 2010. View Article : Google Scholar : PubMed/NCBI
14	Day TF, Mewani RR, Starr J, Li X, Chakravarty D, Ressom H, Zou X, Eidelman O, Pollard HB, Srivastava M and Kasid UN: Transcriptome and proteome analyses of TNFAIP8 knockdown cancer cells reveal new insights into molecular determinants of cell survival and tumor progression. Methods Mol Biol. 1513:83–100. 2017. View Article : Google Scholar : PubMed/NCBI
15	Zhang Z, Liang X, Gao L, Ma H, Liu X, Pan Y, Yan W, Shan H, Wang Z, Chen YH and Ma C: TIPE1 induces apoptosis by negatively regulating Rac1 activation in hepatocellular carcinoma cells. Oncogene. 34:2566–2574. 2015. View Article : Google Scholar : PubMed/NCBI
16	Ye T, Yang B, Wang C, Su C, Luo J, Yang X, Yu H, Yuan Z, Meng Z and Xia J: TIPE1 impairs stemness maintenance in colorectal cancer through directly targeting β-catenin. Carcinogenesis. 41:25–35. 2020.PubMed/NCBI
17	Wu X, Ma Y, Cheng J, Li X, Zheng H, Jiang L and Zhou R: TIPE1 function as a prognosis predictor and negative regulator of lung cancer. Oncotarget. 8:78496–78506. 2017. View Article : Google Scholar : PubMed/NCBI
18	Liu W, Chen Y, Xie H, Guo Y, Ren D, Li Y, Jing X, Li D, Wang X, Zhao M, et al: TIPE1 suppresses invasion and migration through down-regulating Wnt/β-catenin pathway in gastric cancer. J Cell Mol Med. 22:1103–1117. 2018.PubMed/NCBI
19	Cui J, Zhang G, Hao C, Wang Y, Lou Y, Zhang W, Wang J and Liu S: The expression of TIPE1 in murine tissues and human cell lines. Mol Immunol. 48:1548–1555. 2011. View Article : Google Scholar : PubMed/NCBI
20	Shen P, Zhang H, Su Z, Wang S and Xu H: In silico analysis of tumor necrosis factor α-induced protein 8-like-1 (TIPE1) protein. PLoS One. 10:e01341142015. View Article : Google Scholar : PubMed/NCBI
21	Zhao Q, Zhao M, Dong T, Zhou C, Peng Y, Zhou X, Fan B, Ma W, Han M and Liu S: Tumor necrosis factor-α-induced protein-8 like-2 (TIPE2) upregulates p27 to decrease gastic cancer cell proliferation. J Cell Biochem. 116:1121–1129. 2015. View Article : Google Scholar : PubMed/NCBI
22	Wang K, Ren Y, Liu Y, Zhang J and He JJ: Tumor necrosis factor (TNF)-α-induced protein 8-like-2 (TIPE2) inhibits proliferation and tumorigenesis in breast cancer cells. Oncol Res. 25:55–63. 2017. View Article : Google Scholar : PubMed/NCBI
23	Li Y, Li X, Liu G, Sun R, Wang L, Wang J and Wang H: Downregulated TIPE2 is associated with poor prognosis and promotes cell proliferation in non-small cell lung cancer. Biochem Biophys Res Commun. 457:43–49. 2015. View Article : Google Scholar : PubMed/NCBI
24	Gus-Brautbar Y, Johnson D, Zhang L, Sun H, Wang P, Zhang S, Zhang L and Chen YH: The anti-inflammatory TIPE2 is an inhibitor of the oncogenic Ras. Mol Cell. 45:610–618. 2012. View Article : Google Scholar : PubMed/NCBI
25	Liu MW, Liu R, Wu HY, Zhang W, Xia J, Dong MN, Yu W, Wang Q, Xie FM, Wang R, et al: Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression. Int J Mol Med. 38:1419–1432. 2016. View Article : Google Scholar : PubMed/NCBI
26	Zhang H, Zhu T, Liu W, Qu X, Chen Y, Ren P, Wang Z, Wei X, Zhang Y and Yi F: TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury. J Mol Med (Berl). 93:1033–1043. 2015. View Article : Google Scholar : PubMed/NCBI
27	Fayngerts SA, Wu J, Oxley CL, Liu X, Vourekas A, Cathopoulis T, Wang Z, Cui J, Liu S, Sun H, et al: TIPE3 is the transfer protein of lipid second messengers that promote cancer. Cancer Cell. 26:465–478. 2014. View Article : Google Scholar : PubMed/NCBI
28	Yuan F, Liu B, Xu Y, Li Y, Sun Q, Xu P, Geng R, Den G, Yang J, Zhang S, et al: TIPE3 is a regulator of cell apoptosis in glioblastoma. Cancer Lett. 446:1–14. 2019. View Article : Google Scholar : PubMed/NCBI
29	Wang G, Guo C, Zhao H, Pan Z, Zhu F, Zhang L and Wang Q: TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location. BMC Cancer. 18:2602018. View Article : Google Scholar : PubMed/NCBI
30	Ren XY, Wen X, Li YQ, Zhang J, He QM, Yang XJ, Tang XR, Wang YQ, Zhang PP, Chen XZ, et al: TIPE3 hypermethylation correlates with worse prognosis and promotes tumor progression in nasopharyngeal carcinoma. J Exp Clin Cancer Res. 37:2272018. View Article : Google Scholar : PubMed/NCBI
31	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
32	Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and Varambally S: UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
33	Brierley JD, Gospodarowicz MK and Wittekind C: TNM classification of malignant tumours. 8th edition. Wiley-Blackwell; Hoboken: 2016
34	Miao Z, Zhao T, Wang Z, Xu Y, Song Y, Wu J and Xu H: SCC-S2 is overexpressed in colon cancers and regulates cell proliferation. Tumour Biol. 33:2099–2106. 2012. View Article : Google Scholar : PubMed/NCBI
35	Li XM, Su JR, Yan SP, Cheng ZL, Yang TT and Zhu Q: A novel inflammatory regulator TIPE2 inhibits TLR4-mediated development of colon cancer via caspase-8. Cancer Biomark. 14:233–240. 2014. View Article : Google Scholar : PubMed/NCBI
36	Yang C, Xu W, Meng X, Zhou S, Zhang M and Cui D: SCC-S2 facilitates tumor proliferation and invasion via activating Wnt signaling and depressing hippo signaling in colorectal cancer cells and predicts poor prognosis of patients. J Histochem Cytochem. 67:65–75. 2019. View Article : Google Scholar : PubMed/NCBI
37	Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, Ahmad I and Kasid UN: Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, and MMP-9 expression. Mol Ther. 13:947–955. 2006. View Article : Google Scholar : PubMed/NCBI
38	Han Y, Tang Z, Zhao Y, Li Q and Wang E: TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer. Mol Carcinog. 57:159–166. 2018. View Article : Google Scholar : PubMed/NCBI
39	Wu S, Li W, Wu Z, Cheng T, Wang P, Li N, Liang X, Chi M, Zhang S, Ma Y, et al: TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis. Oncol Lett. 17:4667–4674. 2019.PubMed/NCBI
40	Lou Y and Liu S: The tipe (tnfaip8) family in inflammation, immunity, and cancer. Mol Immunol. 49:4–7. 2011. View Article : Google Scholar : PubMed/NCBI
41	Gao HY, Huo FC, Wang HY and Pei DS: MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8. Cell Prolif. 50:e123312017. View Article : Google Scholar
42	Ha JY, Kim JS, Kang YH, Bok E, Kim YS and Son JH: Tnfaip8 l1/Oxi-β binds to FBXW5, increasing autophagy through activation of TSC2 in a Parkinson's disease model. J Neurochem. 129:527–538. 2014. View Article : Google Scholar : PubMed/NCBI
43	Hitomi J, Christofferson DE, Ng A, Yao J, Degterev A, Xavier RJ and Yuan J: Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell. 135:1311–1323. 2008. View Article : Google Scholar : PubMed/NCBI
44	Zhu Y, Tao M, Wu J, Meng Y, Xu C, Tian Y, Zhou X, Xiang J, Zhang H and Xie Y: Adenovirus-directed expression of TIPE2 suppresses gastric cancer growth via induction of apoptosis and inhibition of AKT and ERK1/2 signaling. Cancer Gene Ther. 23:98–106. 2016. View Article : Google Scholar : PubMed/NCBI
45	Zhang YH, Yan HQ, Wang F, Wang YY, Jiang YN, Wang YN and Gao FG: TIPE2 inhibits TNF-α-induced hepatocellular carcinoma cell metastasis via Erk1/2 downregulation and NF-κB activation. Int J Oncol. 46:254–264. 2015. View Article : Google Scholar : PubMed/NCBI
46	Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, Zhu F, Wang Q, Wang J, Wang X, et al: Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer. 12:1492013. View Article : Google Scholar : PubMed/NCBI
47	Zhang W, Zhang J, Zhao L, Shao J, Cui J, Guo C, Zhu F, Chen YH and Liu S: TIPE2 protein negatively regulates HBV-specific CD8+ T lymphocyte functions in humans. Mol Immunol. 64:204–209. 2015. View Article : Google Scholar : PubMed/NCBI
48	Wang Y, Jiang Y, Zhou J, Song W, Li J, Wang M, Chen J, Xu R, Zhang J, Ma F, et al: Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response. Tumour Biol. 37:15265–15274. 2016. View Article : Google Scholar : PubMed/NCBI
49	Shi G, Zhao JW, Sun XX, Ma JF, Wang P, He FC and Ming L: TIPE2 is negatively correlated with tissue factor and thrombospondin-1 expression in patients with bronchial asthma. Exp Ther Med. 15:3449–3454. 2018.PubMed/NCBI